ClinicalTrials.gg
Drug

Dordaviprone clinical trials

Also written ONC201 and TIC10.

studies test it
26
open now
6
in phase 3
2
first study started
2014

How each study uses dordaviprone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the dordaviprone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
6 Aug 2025 · MODEYSO · NDA 219876 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Akt/ERK Inhibitor ONC201
5
Dordaviprone (ONC201)
5
dordaviprone
4
Oral ONC201
2

Brand

Modeyso
1

Development codes

ONC201
20
TIC10
9

Studies by the year they started

26 studies that test it; most in 2015 (5)

Studies that test dordaviprone, by start year
YearStudies
20141
20155
20161
20174
20185
20191
20201
20212
20221
20232
20241
20251
20261

Who runs them

Industry 7 · Other 19

Chimerix (5) · University of Nebraska (2) · National Cancer Institute (NCI) (2) · Fox Chase Cancer Center (2) · Rutgers, The State University of New Jersey (2) · Jazz Pharmaceuticals (2) · M.D. Anderson Cancer Center (2) · Peter Anderson (1)

Often tested with

Tested in the same studies.

Tasadenoturev (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test dordaviprone.

Studies

Open first, then newest update. How each study uses dordaviprone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 26

See all 26 studies that test dordaviprone →

Codes

What other systems call dordaviprone · ClinicalTrials.gg INT006410

  • MeSH (NLM) C585684dordaviproneConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 9U35A31JAIDORDAVIPRONEConfirmed FDA, NLM, Wikidata
  • Wikidata Q27895916DordaviproneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C113792DordaviproneOne source FDA
  • DrugBank DB14844One source Wikidata

Also registered as dordaviprone hydrochloride (UNII 53VG71J90J).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.